Adults 18 to 60, male only, with Sex, Unsafe or Drug Use. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Proportion of Respondents Reporting Any Drug UsePrimary· 30 days prior to assessment
The outcome measure is a dichotomous variable indicating whether or not each participant reported any drug use in the in the 30 days prior to each follow-up assessment. The table below displays the number (and percentage) of participants who indicated the use of any drugs at each assessment wave. Assessments were conducted at 1, 3, and 6 month post intervention.
1 month follow-up
Group
Value
95% CI
CHTC as Usual
25
CHTC + Communication Skills Videos
26
CHTC + Substance Use Module
18
CHTC + Video + Substance Use Module
17
3 month follow-up
Group
Value
95% CI
CHTC as Usual
20
CHTC + Communication Skills Videos
17
CHTC + Substance Use Module
28
CHTC + Video + Substance Use Module
15
6 month follow-up
Group
Value
95% CI
CHTC as Usual
15
CHTC + Communication Skills Videos
31
CHTC + Substance Use Module
15
CHTC + Video + Substance Use Module
17
Condomless Anal Sex With Casual PartnersPrimary· 30 days prior to assessment
The outcome measure is a dichotomous variable indicating whether or not each participant indicated the occurrence of any insertive or receptive condomless anal sex (CAS) with a casual partner in the 30 days prior to each follow-up assessment. The table below displays the number (and percentage) of participants who indicated any CAS with a casual partner at each assessment wave. Assessments were conducted at 1, 3, and 6 month post intervention.
1 month follow-up
Group
Value
95% CI
CHTC as Usual
3
CHTC + Communication Skills Videos
3
CHTC + Substance Use Module
3
CHTC + Video + Substance Use Module
1
3 month follow-up
Group
Value
95% CI
CHTC as Usual
0
CHTC + Communication Skills Videos
5
CHTC + Substance Use Module
6
CHTC + Video + Substance Use Module
2
6 month follow-up
Group
Value
95% CI
CHTC as Usual
3
CHTC + Communication Skills Videos
4
CHTC + Substance Use Module
10
CHTC + Video + Substance Use Module
3
Drug Abuse Screening Test-10 Total ScoresPrimary· 30 days prior to assessment
The scale assesses the number of drug use related problems experienced by the participant in the 30 days prior to the assessment. Higher scores indicate a greater number of drug use related problems. Note, assessments were conducted at 1, 3, and 6 months post intervention.
1 month follow-up
Group
Value
95% CI
CHTC as Usual
2.52
± 2.04
CHTC + Communication Skills Videos
1.70
± 1.75
CHTC + Substance Use Module
1.16
± 1.39
CHTC + Video + Substance Use Module
1.06
± 1.18
3 month follow-up
Group
Value
95% CI
CHTC as Usual
1.98
± 2.01
CHTC + Communication Skills Videos
1.53
± 1.42
CHTC + Substance Use Module
1.40
± 1.85
CHTC + Video + Substance Use Module
0.71
± 0.90
6 month follow-up
Group
Value
95% CI
CHTC as Usual
1.76
± 2.12
CHTC + Communication Skills Videos
1.70
± 1.56
CHTC + Substance Use Module
1.25
± 1.73
CHTC + Video + Substance Use Module
0.84
± 1.00
Sponsor's own description
The proposed study developed and tested two adjunct components for use in Couples HIV Testing and Counseling (CHTC) with gay-male couples: a communication skills training video and a substance use agreement module. Phase I of the study involved the creation of intervention materials and Phase II was comprised of a small randomized controlled trial comparing the additive effects of the novel components to CHTC as usual.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Other trials of Communication skills training video
Trials testing the same drug.
NCT05000866 — Expanding the Potential of Couples HIV Testing: Adjunct Modules to Reduce Drug Use Among Vulnerable Male Couples
· NA
· active not recruiting
Other Hunter College of City University of New York trials
Trials by the same sponsor.
NCT06860932 — A Palliative Care Model Impact on Knowledge and Attitudes
· NA
· recruiting
NCT06505421 — Eccentric Exercise and Fatigue in Multiple Sclerosis
· recruiting
NCT06126107 — Gain and Loss Framed Text Messaging to Reduce Drinking Among Older Adults
· NA
· completed
NCT06094855 — Effect of Cooling on Balance Performance in Multiple Sclerosis
· recruiting
NCT05544578 — Korean Translation and Validation of the K-HEPI in NYC
· NA
· completed
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hunter College of City University of New York
Last refreshed: 15 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03125915.